A Clinical Trial to Evaluate the Immunogenicity and Safety of the 23-valent Pneumococcal Polysaccharide Vaccine in Healthy People

Abroad (travel likely)RecruitingPHASE3

Conditions

Pneumococcal Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Sichuan Center For Disease Control and Prevention, Chengdu, Sichuan, China
Contact: Study coordinator (Xuecheng LIU) · +8618981958206

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy Infants

Pneumococcal Disease

Abroad (travel likely)RecruitingPHASE3

Estero, United States · Fort Lauderdale, United States

A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.

Pneumococcal Disease

Abroad (travel likely)RecruitingPHASE3

Birmingham, United States · Birmingham, United States

Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents

Pneumococcal Disease

Abroad (travel likely)RecruitingPHASE3

Birmingham, United States · Fair Oaks, United States

Induction of Cross-protective Antibodies for Serogroup 33 by Pneumococcal Conjugate Vaccines

Vaccine · Pneumococcal Disease

Abroad (travel likely)RecruitingPHASE4

Birmingham, United States